Tag: Preсlinical Studies

Russian researchers to develop new cancer drug

cancer-test
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin.

Trianni and MacroGenics start cooperation on monoclonal antibodies R&D platform

pre-clinical
Trianni and MacroGenics announced that they have entered into a license agreement for The Trianni Mouse, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies

Scientists from Sechenov University published a new study in stem cell therapy

stem-cells
Research team from Sechenov University published a review of treatment strategies involving mesenchymal stem cells that are used to combat the consequences of ischemic heart disease.

Scientists created a temperature-stable polio vaccine

lab research
Researchers from The Keck School of Medicine of the University of Southern California (USA) have developed a polio vaccine that doesn’t require refrigeration.

Genentech obtains rights to preclinical portfolio of Jecure Therapeutics

drug discovery
Jecure Therapeutics, a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced it will be acquired by Genentech, a member of the Roche Group.

Roivant Sciences licenses a novel investigational biologic from iNtRON Bio

biolab
Roivant Sciences and iNtRON Biotechnology announced that they have entered into a licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious diseases.

Russian scientists started trials for new ankylosing spondylitis drug

research
Scientists of the N.I. Pirogov Russian National Research Medical University began trials of the world's first drug without any side effects for the treatment of an incurable joint disease.

US scientists reports of promising studies on peptide-based cancer vaccine

vaccine-development
The peptide-based vaccine targets specific enzymes called metalloproteinases (MMPs) that are necessary for any cancer to grow tumors, metastasize, and form blood vessels in tumors (angiogenesis).

Concept Life Sciences extends GLP accreditation to support regulatory studies

concept-life-sciences
Concept Life Sciences (UK), the integrated drug discovery and development and analytical services company, today announced the expansion of its regulatory GLP capabilities.

Universal flu vaccine candidate shows promising results in preclinical studies

influenza vaccine
InvVax in collaboration with Trudeau Institute Contract Research Organization and Hong Kong University, announced that it has demonstrated preclinical success for its universal flu vaccine candidate.

Russian drug for tick-borne encephalitis is ready for clinical trials

clinical-trials
The scientists from the Institute of Chemical Biology and Fundamental Medicine have synthesized a substance for a medicinal product for the prevention and treatment of tick-borne encephalitis.

Russian cancer drug based on smallpox vaccine undergoes preclinical studies

research chemistry
Siberian scientists have brought to the final stage of preclinical testing the only Russian therapeutic cancer drug.

Russian TB vaccine has successfully completed preclinical studies

research
Minister of Health of the Russian Federation Veronika Skvortsova made an announcement on the Margins of UN General Assembly.

Stealth BioTherapeutics develops new drug in collaboration with Evotec

clinical-trials
Stealth BioTherapeutics announced that it is advancing a new pipeline candidate into investigational new drug (IND) enabling studies in collaboration with long-term partner Evotec AG.

Researchers developed a new class of drugs to reduce cardiovascular risk

drug-development
Researchers from Cleveland Clinic have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut.

FPI conducts preclinical trials of drug intended to save seriously injured

research
Human trials of the drug being developed to save the seriously injured and to extend the "golden hour" - the time regarded as the most critical for saving lives - can begin at least in three years